EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
INSIDE INFORMATION - UPDATES ON 2025 PRELIMINARY ANNUAL RESULTS
VOLUNTARY ANNOUNCEMENT - MENHYCIA OBTAINS THE NOTIFICATION OF APPROVAL OF SUPPLEMENTAL DRUG APPLICATION
Monthly Return of Equity Issuer on Movements in Securities
INSIDE INFORMATION - RESULTS FORECAST FOR THE YEAR 2025
VOLUNTARY ANNOUNCEMENT - PCV24 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Monthly Return of Equity Issuer on Movements in Securities
VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR DTCP-HIB-MCV4 COMBINED VACCINE
Monthly Return of Equity Issuer on Movements in Securities
List of Directors and their Roles and Functions
Articles of Association
1
2
3
4
5
6
50
津公网安备12011602300399
